Ganjoo K - Search Results

1

Ganjoo K, Advani R, Mariappan MR, McMillan A, Horning S. Ganjoo K, et al. Cancer. 2007 Jul 1;110(1):25-30. doi: 10.1002/cncr.22753. Cancer. 2007. PMID: 17541937 Free article.

2

Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors.

Ganjoo KN, Rieger KM, Kesler KA, Sharma M, Heilman DK, Einhorn LH. Ganjoo KN, et al. Cancer. 2000 Mar 1;88(5):1051-6. doi: 10.1002/(sici)1097-0142(20000301)88:5<1051::aid-cncr15>3.0.co;2-r. Cancer. 2000. PMID: 10699894 Clinical Trial.

3

Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.

Ganjoo KN, An CS, Robertson MJ, Gordon LI, Sen JA, Weisenbach J, Li S, Weller EA, Orazi A, Horning SJ. Ganjoo KN, et al. Leuk Lymphoma. 2006 Jun;47(6):998-1005. doi: 10.1080/10428190600563821. Leuk Lymphoma. 2006. PMID: 16840188 Clinical Trial.

4

Antiangiogenesis: a new approach to the treatment of lymphoma.

Ganjoo K. Ganjoo K. Leuk Lymphoma. 2007 Mar;48(3):454-5. doi: 10.1080/10428190701200059. Leuk Lymphoma. 2007. PMID: 17454583 No abstract available.

5

The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients.

Ganjoo KN, Moore AM, Orazi A, Sen JA, Johnson CS, An CS. Ganjoo KN, et al. J Cancer Res Clin Oncol. 2008 Mar;134(3):381-7. doi: 10.1007/s00432-007-0294-x. Epub 2007 Aug 11. J Cancer Res Clin Oncol. 2008. PMID: 17694324

6

131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma.

Iagaru A, Mittra ES, Ganjoo K, Knox SJ, Goris ML. Iagaru A, et al. Among authors: ganjoo k. Mol Imaging Biol. 2010 Apr;12(2):198-203. doi: 10.1007/s11307-009-0245-9. Epub 2009 Jun 20. Mol Imaging Biol. 2010. PMID: 19543946

7

Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a Multicenter Study.

Kahl BS, Bartlett NL, Leonard JP, Chen L, Ganjoo K, Williams ME, Czuczman MS, Robinson KS, Joyce R, van der Jagt RH, Cheson BD. Kahl BS, et al. Among authors: ganjoo k. Cancer. 2010 Jan 1;116(1):106-14. doi: 10.1002/cncr.24714. Cancer. 2010. PMID: 19890959 Free PMC article. Clinical Trial.

8

Antiangiogenesis agents in the treatment of soft tissue sarcomas.

Ganjoo K, Jacobs C. Ganjoo K, et al. Cancer. 2010 Mar 1;116(5):1177-83. doi: 10.1002/cncr.24859. Cancer. 2010. PMID: 20052715 Free article. Review.

9

A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer.

Clément-Duchêne C, Krupitskaya Y, Ganjoo K, Lavori P, McMillan A, Kumar A, Zhao G, Padda S, Zhou L, Pedro-Salcedo MS, Colevas AD, Wakelee HA. Clément-Duchêne C, et al. Among authors: ganjoo k. J Thorac Oncol. 2010 Nov;5(11):1821-5. doi: 10.1097/JTO.0b013e3181f1d23c. J Thorac Oncol. 2010. PMID: 20881641 Free PMC article. Clinical Trial.

10

Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial.

Advani RH, Hong F, Horning SJ, Kahl BS, Manola J, Swinnen LJ, Habermann TM, Ganjoo K. Advani RH, et al. Among authors: ganjoo k. Leuk Lymphoma. 2012 Apr;53(4):718-20. doi: 10.3109/10428194.2011.623256. Epub 2011 Dec 5. Leuk Lymphoma. 2012. PMID: 21916830 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters